Brazil Leukemia Therapeutics Market Analysis


  • Type: Oncology area
  • Published : May 2021
  • Region: LATAM
  • Country: Brazil
  • Report ID : 4528

  • Format: PPT, PDF

Brazil Leukaemia Therapeutics Market Analysis: Segmented by Treatment Type (Chemotherapy, Radiation Therapy, Immunotherapy, Surgery, Targeted Therapy, Bone marrow transplant and Stem cell therapy), By Drug Class (Hyper-CVAD Regimen, Linker Regimen, Nucleoside Metabolic Inhibitors, Targeted Drugs & Immunotherapy, CALGB 8811 Regimen and Oncaspar) and By Demographics (Pediatrics and Adults) – Growth, Trends, and Forecasts (2019 – 2028)


Report Overview

The Brazil Leukemia Therapeutics size stood at USD xx million in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.

Leukemia therapeutics is a haematological cancer of blood-forming tissues, including the blood components and bone marrow. It is occurred when bone marrow produces damaged lymphocytes which causes dysfunctional in production of antibodies and ultimately lost the ability to fight against infections. The various factors such as genetic mutation and family history of leukaemia are major causes of leukaemia.

Market Drivers

The leukemia therapeutics market is expected to witness high growth due to rising incidences of chronic diseases. Leukemia is identified by the spread of disease (acute and chronic) commonly caused due to exposure to radiation, unhealthy lifestyle habits, and environmental factors. Increasing geriatric population base and high unmet needs regarding early diagnosis and treatment of leukemia are the key factors driving the market.

Additionally, increasing investments in the R&D sector, introduction of novel therapies with more efficiency & fewer side effects.

Major types of Leukaemia

The leukemia therapeutics market includes types of diseases such as chronic lymphatic leukemia, acute lymphatic leukemia, chronic myeloid leukemia, and acute myeloid leukemia.  The chronic myeloid leukemia market dominated the overall therapeutic market owing to high prevalence rate, high drug treatment rates and rapid uptake of second-generation tyrosine kinase inhibitors.

1. Brazil Leukaemia Therapeutics Market Overview………………………..
A. Market Size
2. Market Growth Drivers …………………………………………………………………..
A. Rising incidences of chronic diseases
B. Exposure to radiation, unhealthy lifestyle habits, and environmental factors
C. Increasing geriatric population base and high unmet needs
3. Major types of Leukaemia…………………………………………….
A. Acute Lymphocytic Leukaemia (ALL)
B. Chronic Lymphocytic Leukaemia (CLL)
C. Acute Myeloid Leukaemia (AML)
D. Acute Myeloid Leukaemia (CML)
4. Leukaemia Therapeutics Market Segmentation…………………………………….
A. By Treatment Type
I. Chemotherapy
II. Radiation Therapy
III. Immunotherapy
IV. Surgery
V. Targeted Therapy
VI. Bone marrow transplant
VII. Stem cell therapy
B. By Drug Class
I. Hyper-CVAD Regimen
II. Linker Regimen
III. Nucleoside Metabolic Inhibitors
IV. Targeted Drugs & Immunotherapy
V. CALGB 8811 Regimen
VI. Oncaspar
C. By Demographics
I. Pediatrics
II. Adults
5. Leukaemia Therapeutics Major Market Share….……………………………
A. Market Analysis, Insights and Forecast – By Revenue
6. Competitive Landscape………………………………………………………………….
A. Major Players
B. Products in Pipeline
7. Key Company Profiles……………………………………………………………………
A. AbbVie Company overview, Product & Services, Strategies & Financials
B. Pfizer Inc. Company overview, Product & Services, Strategies & Financials
C. Takeda Pharmaceutical Company, Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape…………………………………….
A. Policy changes and Reimbursement scenario
9. Factors Driving Future Growth…………………………………………………………
A. New Trends and Development in Leukaemia Therapeutics Market
B. Future Opportunities
10. Conclusion

Market Segmentation

By Treatment Type:

Treatment segment market includes chemotherapy, radiation therapy, immunotherapy, surgery, targeted therapy, bone marrow transplant and stem cell therapy. For acute lymphatic leukemia radiation therapy and chemotherapy treatments were the most popularly used methods. Subtypes of acute lymphatic leukemia consist of segments such as precursor T acute lymphatic leukemia, precursor B acute lymphatic leukemia, acute biphenotypic leukemia, and burkitt leukemia. Chemotherapy hyper CVAD treatment dominated the market for chemotherapy treatments.

Stem cell therapy and bone marrow transplant are the emerging trends in the leukemia therapeutics market and are expected to boost market growth.

By Drugs class:

Based on drug, the market is divided into Hyper-CVAD Regimen, Linker Regimen, Nucleoside Metabolic Inhibitors (Clolar and Nelarabine), Targeted Drugs & Immunotherapy, CALGB 8811 Regimen, and Oncaspar. The Hyper-CVAD Regimen acquired the largest acute lymphocytic/lymphoblastic leukemia therapeutics market share owing to wide usage in the ALL treatment. Hyper-CVAD Regimen is considered as one of the most commonly used therapy options for acute lymphocytic/lymphoblastic leukemia.

Furthermore, targeted drugs & immunotherapy are projected to grow at the fastest rate during the forecast period as these drugs have shown potential in the treatment of relapsed acute lymphocytic leukemia and is widely used in patients who do not respond to chemotherapy.

By Demographics:

Based on demographics, it is classified into pediatrics and adults. According to type, the pediatrics segment generated the highest revenue and is expected to maintain its dominance throughout the forecast period. This is attributed to the high incidences of acute lymphocytic leukemia among pediatric population. Acute lymphocytic leukemia is considered as one of the most common cancer types in pediatric population. Moreover, pediatric population have higher success rate for acute lymphocytic/lymphoblastic leukemia treatments.

Top Major Players

Major market players are Pfizer, Novartis AG, Roche, AbbVie, Takeda Pharmaceutical etc. Companies are adopting novel growth strategies such as product launch, merger & acquisitions, product pipeline, clinical trials, and collaboration & agreements, to gain competitive advantage.

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.

    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements